Type 1 Diabetes Mellitus and Autoimmune Diseases: A Critical Review of the Association and the Application of Personalized Medicine

Author:

Popoviciu Mihaela Simona1,Kaka Nirja23,Sethi Yashendra24ORCID,Patel Neil23ORCID,Chopra Hitesh5ORCID,Cavalu Simona1ORCID

Affiliation:

1. Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania

2. PearResearch, Dehradun 248001, India

3. Department of Medicine, GMERS Medical College, Himmatnagar 383001, India

4. Department of Medicine, Government Doon Medical College, HNB Uttarakhand Medical Education University, Dehradun 248001, India

5. Chitkara College of Pharmacy, Chitkara University, Rajpura 140401, India

Abstract

Type 1 Diabetes Mellitus (T1DM) is a common hyperglycemic disease characterized by the autoimmune destruction of insulin-producing beta cells of the pancreas. Various attempts have been made to understand the complex interplay of genetic and environmental factors which lead to the development of the autoimmune response in an individual. T1DM is frequently associated with other autoimmune illnesses, the most common being autoimmune thyroid disorders affecting more than 90% of people with T1D and autoimmune disorders. Antithyroid antibodies are present in around 20% of children with T1D at the start of the illness and are more frequent in girls. Patients with T1DM often have various other co-existing multi-system autoimmune disorders including but not limited to thyroid diseases, parathyroid diseases, celiac disease, vitiligo, gastritis, skin diseases, and rheumatic diseases. It is a consistent observation in clinics that T1DM patients have other autoimmune disorders which in turn affect their prognosis. Concomitant autoimmune illness might affect diabetes care and manifest itself clinically in a variety of ways. A thorough understanding of the complex pathogenesis of this modern-day epidemic and its association with other autoimmune disorders has been attempted in this review in order to delineate the measures to prevent the development of these conditions and limit the morbidity of the afflicted individuals as well. The measures including antibody screening in susceptible individuals, early identification and management of other autoimmune disorders, and adoption of personalized medicine can significantly enhance the quality of life of these patients. Personalized medicine has recently gained favor in the scientific, medical, and public domains, and is frequently heralded as the future paradigm of healthcare delivery. With the evolution of the ‘omics’, the individualization of therapy is not only closer to reality but also the need of the hour.

Funder

University of Oradea, Romania

Publisher

MDPI AG

Subject

Medicine (miscellaneous)

Reference113 articles.

1. Speight, J., and Pouwer, F. (2022). Cambridge Handbook of Psychology, Health and Medicine, Cambridge University Press. [3rd ed.].

2. Prevalence and Incidence of Type 1 Diabetes in the World: A Systematic Review and Meta-Analysis;Mobasseri;Health Promot. Perspect.,2020

3. Effect of Associated Autoimmune Diseases on Type 1 Diabetes Mellitus Incidence and Metabolic Control in Children and Adolescents;Krzewska;BioMed Res. Int.,2016

4. Type 1 Diabetes and Polyglandular Autoimmune Syndrome: A Review;Hansen;World J. Diabetes,2015

5. Thyroid Dysfunction and Diabetes Mellitus: Two Closely Associated Disorders;Biondi;Endocr. Rev.,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3